Affordable Access

Direct Measurement of the Anti-Influenza Agent Zanamivir in the Respiratory Tract following Inhalation

Authors
Publisher
American Society for Microbiology
Publication Date
Source
PMC
Keywords
  • Pharmacology

Abstract

In a single-center, randomized study, zanamivir (Relenza) concentrations in induced sputum samples and nasal washings of healthy adults following oral inhalation were measured. Concentrations in sputum exceeded the median viral neuraminidase 50% inhibitory concentration at 6, 12, and 24 h, and those in nasal washings did so at 6 and 12 h. There were no zanamivir-related adverse events or laboratory abnormalities.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments